Umthetho we-Orphan Drug Act ukusekela izifo ezinzima

Indlela Ucwaningo Nokuthuthukiswa Kwezidakamizwa Zezintandane Kunconywa

Iyini isidakamizwa sezintandane nokuthi yimuphi umthetho we-Orphan Drug Act? Kungani ucwaningo nentuthuko yalezi zidakamizwa zibalulekile futhi yiziphi izithiyo?

Iyini i-Orphan Drug? - Incazelo

Isidakamizwa sezintandane imithi (imithi) ehlala ingathuthuki ngenxa yokuntuleka kwenkampani ukuthola inzuzo yemithi. Ngokuvamile isizathu sokuthi lesi sidakamizwa asizuzi ukuthi kunabantu abambalwa abazokuthenga lesi sidakamizwa uma kulinganiswa nokucwaninga nokuthuthukiswa okudingekayo ukukhiqiza lesi sidakamizwa.

Ngamazwi alula, izidakamizwa zezintandane yizo izinkampani ezingalindele ukwenza imali eningi, futhi esikhundleni salokho ziqondisa imizamo yazo ezidakamizwa ezizoletha imali.

Okwenza Abanye Izidakamizwa "Ziyizintandane"

Izinkampani zokwelapha (izidakamizwa) nezinkampani ze-biotech ziqhubeka zicwaninga futhi zithuthukisa imishanguzo emisha yokwelapha izimo zezokwelapha, futhi izidakamizwa ezintsha zifika emakethe njalo. Abantu ababhekene nezifo ezingavamile noma ukuphazamiseka, ngakolunye uhlangothi, aboni ukuhlola okufanayo kwezidakamizwa ngezifo zabo. Lokhu kungenxa yokuthi izinombolo zabo zincane futhi ngakho-ke imakethe engaba khona yezidakamizwa ezintsha zokwelapha lezi zifo ezingavamile (ngokuvamile ezibhekwa ngokuthi "izidakamizwa zezintandane") nazo zincane.

Isifo esingavamile senziwa ngabantu abangaphansi kuka-200,000 e-United States noma abangaphansi kuka-5 ngabangu-10 000 abantu base-European Union. Izinhlaka zikahulumeni zokulawula e-United States naseYurophu Union ziye zathatha izinyathelo zokunciphisa lokhu okungafani nokuthuthukiswa kwezidakamizwa

Izikhuthazo zokwandisa ukuthuthukiswa kwezidakamizwa zezintandane

Ukuqaphela ukuthi izidakamizwa ezanele ngezifo ezingavamile ezingakaze zakhiwe e-US kanti lezo zinkampani ezidakamizwa ziyoholela ekulahlekelweni kwezimali ekuthuthukiseni izidakamizwa ezimweni ezingavamile, i-US Congress yadlulisa uMthetho we-Orphan Drug Act ngo-1983.

Ihhovisi lase-US Lokuthuthukiswa Komkhiqizo Wezintandane

I-US Food and Drug Administration (FDA) inesibopho sokuqinisekisa ukuphepha nokusebenza kwemithi emakethe e-United States.

I-FDA yasungula iHhovisi leNtuthuko yomkhiqizo wezintandane (OOPD) ukusiza ekuthuthukiseni izidakamizwa zezintandane (neminye imikhiqizo yezokwelapha ngezifo ezingavamile), kufaka phakathi ukunikeza izibonelelo zocwaningo.

Izidakamizwa zezintandane, njengezinye izidakamizwa, zitholakala ziphephile futhi ziphumelele ngokucwaninga nokuhlolwa kwemitholampilo ngaphambi kokuba i-FDA izobavumela ukuthengisa.

Umthetho We-Orphan Drug Act ka-1983

Umthetho we-Orphan Drug Act unikeza amandla okukhuthaza izinkampani ukuba zihlakulele izidakamizwa (nezinye imikhiqizo yezokwelapha) ezimakethe ezincane zabantu abanezinkinga ezingavamile (e-US, amaphesenti angu-47 ezinkinga ezingavamile ezingathinta abantu abangaphansi kuka-25 000). Lezi zikhuthazo zihlanganisa:

Ngaphambi kokuya komthetho we-Orphan Drug Act, izidakamizwa ezimbalwa zezintandane zitholakalayo ukuphatha izifo ezingavamile.

Kusukela eMthethweni, izidakamizwa ezingaphezu kuka-200 zezintandane ziye zavunywa yi-FDA yokuthengisa e-US

Umthelela we-Orphan Drug Act ku-US Pharmaceuticals

Njengoba uMthetho Wezidakamizwa Wama-Orphan waba ngo-1983, kuye kwaba nomthelela ekuthuthukiseni izidakamizwa eziningi. Ngo-2012 bekukhona okungenani izidakamizwa ezingama-378 ezivunyiwe ngale nqubo, futhi inombolo iyaqhubeka ukukhuphuka.

Isibonelo sezidakamizwa ezitholakala ngenxa yomthetho wezidakamizwa zezintandane

Phakathi kwezidakamizwa ezivumile zihlanganisa lezo ezifana nalezi:

Ucwaningo Lwezwe Lonke Nokuthuthukiswa Kwezidakamizwa Zezintandane

Njenge-US Congress, uhulumeni wase-European Union (EU) uye waqaphela isidingo sokwandisa ucwaningo nokuthuthukiswa kwezidakamizwa zezintandane.

IKomidi leMithi yokwelapha yezintandane

Isungulwe ngo-1995, i-European Medicines Agency (EMEA) inesibopho sokuqinisekisa ukuphepha nokusebenza kwemithi emakethe e-EU. Ihlanganisa ndawonye izinsizakalo zesayense zamazwe angama-25 e-EU. Ngo-2000, iKomidi leMithi yokwelapha ye-Orphan (COMP) yasungulwa ukuze libheke ukuthuthukiswa kwezidakamizwa zezintandane e-EU.

Umthethonqubo weMithi Yezintandane

Umthethonqubo weMithi Yezintandane, eyadluliselwa yiMkhandlu waseYurophu, uhlinzeka ngokugqugquzela izidakamizwa zezintandane (neminye imikhiqizo yezokwelapha ngezifo ezingavamile) e-EU, kufaka phakathi:

Umthethonqubo weMithi yokwelapha yezintandane uye waba nethonya elifanayo elizuzayo e-EU ukuthi uMthetho we-Orphan Drug Act wayese-US, ukwandisa kakhulu ukuthuthukiswa nokukhangiswa kwezidakamizwa zezintandane ngenxa yezifo ezingavamile.

Ngaphansi kwe-Orphan Drug Act

Ngaleso sikhatsi kunengxabano enkulu phezu kwe-Orphan Drug Act, ngesidingo sokwelashwa kwezifo ezingavamile ngakwesinye kwezinga, kanye nemibono mayelana nokusimama komunye. Ngokujabulisayo, lezi zenzo, kokubili e-United States naseYurophu ziye zaphakamisa ukuqwashisa izifo eziningi ezingavamile, okuthi, uma zengezwe ndawonye, ​​akuzona zonke izinto ezingavamile.

Imithombo:

Herder, M. Iyini Inhloso Ye-Orphan Drug Act? . PLoS Medicine . 2017. 14 (1): e1002191.

Murphy, S., Puwanant, A., no R. Griggs. Imiphumela engavumelekile yokuqokwa komkhiqizo wezintandane ngenxa yezifo eziningana ze-Neurological Disorders. Ama-Annal of Neurology . 2012. 72 (4): 481-490.

Ukuphathwa kwe-US nokuDrug. Ukuklama Umkhiqizo Wezintandane: Izidakamizwa Nemikhiqizo Yezinto Eziphilayo. Kubuyekezwe 05/02/16. https://www.fda.gov/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/default.htm